Taylor, C J

HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy. [electronic resource] - Transplantation proceedings Feb 1993 - 210-1 p. digital

Publication Type: Journal Article

0041-1345


Antilymphocyte Serum--therapeutic use
Costs and Cost Analysis
Cyclosporine--therapeutic use
Graft Rejection
HLA-DR Antigens--analysis
Histocompatibility Testing
Humans
Immunosuppression Therapy--methods
Kidney Transplantation--economics
Prednisolone--therapeutic use
Retrospective Studies
Survival Analysis
Transplantation, Homologous